Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Cancer Chemotherapy and Pharmacology
|
February 3, 2011
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group
H H Yoon, P Catalano, M K Gibson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 3, 2011
Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer
A Argiris, M V Karamouzis, R Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 15, 2016
Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer
A Argiris, J E Bauman, J Ohr, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Cancer Chemotherapy and Pharmacology
|
February 3, 2011
Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group
H H Yoon, P Catalano, M K Gibson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 3, 2011
Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer
A Argiris, M V Karamouzis, R Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 15, 2016
Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer
A Argiris, J E Bauman, J Ohr, et al.
Page
of 2